What are Regeneron Pharmaceuticals's profit margins?

Regeneron Pharmaceuticals (REGN) runs a 93.9% gross margin and a 24.3% operating margin, with a 29.6% net margin.

Where do Regeneron Pharmaceuticals's ratios come from?

Every ratio is computed from Regeneron Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Regeneron Pharmaceuticals REGN Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	102.2%-2.9pp	105.1%-3.2pp	108.2%-2.8pp	111%-1.9pp	112.9%-2.2pp
Net margin	124.6%-2.3pp	126.8%+0.3pp	126.5%-1.5pp	128%-0.7pp	128.7%+2.5pp
Returns
Return on equity	59.9%-1.4pp	61.4%-1.1pp	62.4%-2.0pp	64.4%-1.2pp	65.6%+0.7pp
Return on invested capital	43%-2.0pp	45%-3.1pp	48%-2.7pp	50.7%-1.9pp	52.6%-2.5pp
Efficiency
Asset turnover	1.5×0.0×	1.5×0.0×	1.5×0.0×	1.6×0.0×	1.6×0.0×
Liquidity
Current ratio	16.4×-1.4×	17.7×-0.6×	18.3×-1.2×	19.5×-0.8×	20.4×-0.3×
Leverage
Debt-to-equity	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×
Net debt / EBITDA	0.1×0.0×	0.1×-0.1×	0.2×-0.1×	0.3×0.0×	0.3×-0.1×
Per Share
Book value per share	$1,144.05+2.5%	$1,116.56+3.0%	$1,083.77+3.5%	$1,047.36+3.1%	$1,016.10+3.0%
Valuation
Market capitalization	$278.79B+4.6%	$266.44B+1.1%	$263.6B-17.0%	$317.64B-15.2%	$374.55B-8.4%
Price / earnings	62.1×+3.1×	59.1×+0.3×	58.8×-11.4×	70.2×-13.6×	83.8×-11.5×
Price / sales	19.3×+0.6×	18.7×+0.1×	18.6×-4.0×	22.6×-4.4×	27×-3.0×
Price / book	9×+0.2×	8.8×-0.1×	8.8×-1.9×	10.8×-2.1×	12.9×-1.5×
EV / EBITDA	66.5×+3.6×	62.9×+2.0×	60.8×-11.5×	72.4×-13.1×	85.4×-8.3×
Dividend yield	1.7%+0.3pp	1.4%+0.5pp	0.9%+0.5pp	0.5%+0.3pp	0.1%—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Regeneron Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Regeneron Pharmaceuticals's profit margins?: Regeneron Pharmaceuticals (REGN) runs a 93.9% gross margin and a 24.3% operating margin, with a 29.6% net margin.
Where do Regeneron Pharmaceuticals's ratios come from?: Every ratio is computed from Regeneron Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.